| Barr Supplements Limited |
| Financial statements for the year ended 31 March 2025 |
|
| Chartered Accountants' report to the board of directors on the preparation of the unaudited financial statements of Barr Supplements Limited for the year ended 31 March 2025 |
|
| In order to assist you to fulfil your duties under the Companies Act 2006 we have prepared for your approval the financial statements of Barr Supplements Limited for the year ended 31 March 2025, which comprise the Profit and Loss Account, the Balance Sheet and the related notes, from the company’s accounting records and from information and explanations you have given us. |
| As a practising member firm of the Institute of Chartered Accountants in England and Wales we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance. |
| This report is made solely to the Board of Directors of Barr Supplements Limited, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Barr Supplements Limited and state those matters that we have agreed to state to the Board of Directors of Barr Supplements Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Barr Supplements Limited and its Board of Directors, as a body, for our work or for this report. |
| It is your duty to ensure that Barr Supplements Limited has kept adequate accounting records and to prepare financial statements that give a true and fair view of the assets, liabilities, financial position and profit or loss of Barr Supplements Limited. You consider that Barr Supplements Limited is exempt from the statutory audit requirement for the year. |
| We have not been instructed to carry out an audit or a review of the financial statements of Barr Supplements Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements. |
|
| Cavendish Bond |
| Chartered Accountants |
| Bentinck House |
| 3 - 8 Bolsover Street |
| London |
| W1W 6AB |
|
| 29 December 2025 |
|
| Barr Supplements Limited |
| Financial statements for the year ended 31 March 2025 |
|
| Balance Sheet |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Fixed assets |
| Tangible assets |
3 |
|
|
9,817 |
|
|
6,713 |
|
| Current assets |
| Stocks |
|
|
60,600 |
|
|
19,845 |
| Debtors |
4 |
|
137,023 |
|
|
81,426 |
| Cash at bank and in hand |
|
|
30,377 |
|
|
54,112 |
|
|
|
228,000 |
|
|
155,383 |
|
| Creditors: amounts falling due within one year |
5 |
|
(68,405) |
|
|
(42,816) |
|
| Net current assets |
|
|
|
159,595 |
|
|
112,567 |
|
| Total assets less current liabilities |
|
|
|
169,412 |
|
|
119,280 |
|
|
| Provisions for liabilities |
|
|
|
(1,858) |
|
|
(1,678) |
|
|
| Net assets |
|
|
|
167,554 |
|
|
117,602 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
2 |
|
|
2 |
| Profit and loss account |
|
|
|
167,552 |
|
|
117,600 |
|
| Shareholders' funds |
|
|
|
167,554 |
|
|
117,602 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. |
| The financial statements have been prepared in accordance with the special provisions for small companies within Part 15 of the Companies Act 2006. The company's profit and loss account for the year has not been delivered to the Registrar of Companies. |
| These financial statements were approved by the board on 29 December 2025 and are signed on its behalf by |
|
|
|
| R J Barr |
| Director |
|
| Company registration number 12539803 |
|
| Barr Supplements Limited |
| Financial statements for the year ended 31 March 2025 |
|
| Notes to the Financial Statements |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland, as applicable to companies subject to the small entities regime. |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover represents revenue earned from the sale of goods. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Computer equipment |
over 3 years |
|
Fixtures and fittings |
over 5 years |
|
|
Stocks |
|
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised. |
|
|
Debtors |
|
Short term debtors are measured at transaction price less any provision for bad and doubtful debts. Loans and other financial assets are initially recognised at fair value, taking account of any transaction costs, and are subsequently measured at amortised cost using the effective interest method, less any impairment losses. |
|
|
Creditors |
|
Short term creditors are measured at the transaction price. Loans and other financial liabilities are initially recognised at fair value, taking account of any transaction costs, and are subsequently measured at amortised cost using the effective interest method. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference. Current and deferred tax assets and liabilities are not discounted. |
|
Foreign currency translation |
|
Transactions in foreign currencies are initially recognised at the rate of exchange prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the balance sheet date using the rates of exchange prevailing at the balance sheet date. Gains and losses arising from retranslation are recognised in the profit and loss account. Non-monetary items denominated in foreign currencies that are measured at historical cost are translated at the rate ruling at the date of the transaction and are not subsequently retranslated. |
|
|
Financial instruments |
|
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its liabilities.
Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument those financial instruments are classified as financial liabilities and are presented as such in the balance sheet.
Where the contractual terms of financial instruments do not meet the definition of a financial liability those financial instruments are classified as equity instruments. Dividends and other distributions relating to equity instruments are debited directly to equity. |
|
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
- |
|
- |
|
|
|
|
|
|
|
|
|
|
| 3 |
Tangible fixed assets |
|
|
|
|
Computer equipment |
|
Fixtures and fittings |
|
Total |
| £ |
£ |
£ |
|
Cost |
|
At 1 April 2024 |
4,492 |
|
7,672 |
|
12,164 |
|
Additions |
906 |
|
5,912 |
|
6,818 |
|
At 31 March 2025 |
5,398 |
|
13,584 |
|
18,982 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 April 2024 |
3,102 |
|
2,349 |
|
5,451 |
|
Charge for the year |
997 |
|
2,717 |
|
3,714 |
|
At 31 March 2025 |
4,099 |
|
5,066 |
|
9,165 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 March 2025 |
1,299 |
|
8,518 |
|
9,817 |
|
At 31 March 2024 |
1,390 |
|
5,323 |
|
6,713 |
|
|
|
|
|
|
|
|
|
|
| 4 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade debtors |
61,019 |
|
56,826 |
|
Other debtors |
76,004 |
|
24,600 |
|
|
|
|
|
|
137,023 |
|
81,426 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade creditors |
28,539 |
|
10,355 |
|
Taxes and social security costs |
28,351 |
|
25,313 |
|
Other creditors |
11,515 |
|
7,148 |
|
|
|
|
|
|
68,405 |
|
42,816 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Other financial commitments |
2025 |
|
2024 |
| £ |
£ |
|
|
Total future minimum payments under non-cancellable operating leases |
|
24,856 |
|
- |
|
|
|
|
|
|
|
|
|
|
| 7 |
Related party transactions |
|
|
At the balance sheet date the company was owed £63,787 (2024: £23,013) by its director. This balance has been repaid. |
|
|
| 8 |
Other information |
|
|
Barr Supplements Limited is a private company limited by shares and incorporated in England. Its registered office is: |
|
|
C/O Cavendish Bond |
|
Bentinck House |
|
3 - 8 Bolsover Street |
|
London |
|
W1W 6AB |